Skip to main content
. 2014 Nov 20;78(6):1264–1271. doi: 10.1111/bcp.12479

Table 1.

Characteristics of included studies

Study characteristic Rufinamide Placebo
Study number Authors Year Multicentre Randomized Reported adverse events Patients treated Patients treated
1 Palhagen et al. [15] 2001 9 1:1 ratio Fatigue, headache and dizziness 25 25
2 Glauser et al. [5] 2008 36 Blocks of four, centre level Somnolence 74 64
3 Elger et al. [14] 2010 Yes* 1:1 ratio Fatigue, headache, dizziness and somnolence 262 133
4 Biton et al. [11] 2011 65 1:1 ratio Fatigue, headache, dizziness and somnolence 176 180
5 Brodie et al. [10] 2009 48 1:1 ratio Fatigue, headache, dizziness and somnolence 156 157
*

Number of centres is not mentioned in the original article.